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T he management of cn(l-stagc oronary artery dis- case that is refractor) to surgical or i)erentaneous 
revascularization techniques and unresponsive tomed- 
ical therapy rcnmins a challenge for patients and their 
doctors. The synqltoms of persistent and recurrent 
an~nal attacks are severe and debilitating, limiting the 
quality of life and inhibiting work and recreational 
capabilities. The social, financial, and cnmtional inl- 
pact can be ovcrwllelming. Medications (e.g., nitrates, 
beta-blockers, and calcium cllanncl antagonists), per- 
cutaneous transcoronary an~oplasty or stenting, and 
coronary artery bypass urgery are widely used to treat 
this condition. In some patients, however, these efforts 
have been exhausted, yet persistent and recnrrent an- 
gina continues with relatively well-preserved myocar- 
dial function. 
Initial attcml)tS at direct revaseularization f the 
heart were considered as early as 1950, when Sen and 
others used blunt instruments to create transmural 
channels in canine hearts. Tiffs so-called "transmyo- 
cardial acupuncture" technique achieved significant 
improvement in survival and reduction in infarct size) 
The proposed mechanism of action is increased myo- 
cardial blood flow through the created channels. Sul)- 
sequently, in 1982 Mirhoseini and others reported the 
first use of the C02 laser to create channels as an 
adjunct o bypass surgery. 2 In 1998, transmyocardial 
laser revascularization (TMR) was approved by the 
FDA for use in patients with disease refractory to other 
treatments. Tim pilot studies demonstrated improved 
patient's anginal score and exercise tolerance, de- 
creased frequency of hospitalizations, and decreased 
need for medications to control symi)toms. Currently, 
these procedures arc performed with a holmium: YAG 
or CO 2 laser. 
Ahhough muhil)le meelmnisms to exi)lain the benefi- 
cial effect of laser TSIR have bccn hypothesized, few 
contend that long-term l)atcncy of the channels rcsuhs. 
The develoi)mcnt of new capillaries from preexisting 
ones has been (lemonstratcd, z,t and delayed thallium 
studies have shown a moderate increase in regional 
blood flow. Additionally, histologic stndics have dem- 
onstrated cncrvation, 5 which, alone or in conjunction 
with these other effects, may result in decreased an- 
gina. 
The additional peripheral effects of tim TMR laser 
result from tlle absorption of laser radiation in the 
surrounding tissncs and the subsequent temperature 
and pressure rise. There is thernml diffusion and dam- 
age 6 and a surrounding thermo-acoustic injury that 
incites an inflammatory esponse around tile clmnncF ,a 
(Fig. 1A). Microvascular structures may be sealed and 
burned by the laser energy. The TMR laser also creates 
sufficient thermal injury to increase peri-clmnnel fibro- 
sis anti cause acoustic shockwave injury a distance 
from tim myocardium, as demonstrated by myocyte 
orientation changes. '~
Ahernative mechanisms used in efforts to create 
transnmral channels and stimulate an angiogenic effect 
on the myocardium lmve included needles and 1/16- 
inch power drill bits./~ A transmyocardial channeling 
(TMC) system has been developed and investigated ini- 
tially in a series of swine experiments and later in a 
limited initial human clinical trial. 
The Trans lnyocard ia l  Channclhlg System 
Tile TMC system is designed to perform myocardial 
revascularization by creating X-ram diameter transmu- 
ral channels during a surgical procedure (Fig. 1B). 
This system uses a hand-hehl device with an extended 
canmda and a rotating hollow coring needle (Fig. 2). 
Tile cannula is connected l)y cable to a console that 
provides tlle mechanism for a <2000-rpm rotation as 
well as a constant anti controlled source of vacuum. 
Tile device creates transnmral channels through tim 
ventricular wall by mechanical coring from the epicar- 
dial surface through to the endocardium. It can be set 
at an assigned epth of penetration anti aspirates the 
tissue in the core. Actuation of the device lmndle ini- 
tiates channeling, after which the rotating hollow nee- 
die advances forward to create the channel. Core aspi- 
rate is vacuumed into a container, confirming complete 
penetration of tim myocardium. This procedure is com- 
pleted at each treatment site. 
Tile tip of tlle handpiece articulates and is adjustable 
to allow tlle device to be positioned on tlle epicardial 
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1 (A) Thermal and acoustic injury surrounding a TMR laser 
channel with creation of tissue debris. (B) A TMC created 
channel with aspiration of the tissue core and x~ithout sur- 
rounding tissue injury. 
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IIand-hehl device with a malleable tip and a rotating hollow coring needle. 
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surface in the anterior, lateral, or posterior e ,on  of 
the heart. The stabilizer ing facilitates the stabiliza- 
tion of the cannnla at the surf~ce and the proper 
trajectory of the coring needle. The procedure can be 
performed through thoracotomy (Fig. 3) or sternotomy 
(Fig. 4) as a sole therapy or in conjunction with coro- 
nary bypass. The console requires minimal setup time 
an electrical power source, anti wall suction. It is light, 
portable, anti very mobile. 
Anticipated candidates for tiffs procedure are similar 
to those for transmyocardial l ser revascularization. 
They should have class III or IV an~na and coronary 
disease not amenable to percutaneous or sur~cal tiler- 
apy. Ventricular function should be preserved such 
that significant congestive heart failure is not an accom- 
panying symptom. Resting and reperfusion thallium 
studies should be performed to identify the areas in 
which to concentrate the channeling procedure. The 
patient should be counseled about the probability of 
rednction of symptoms, and also that neither prolon- 
gation of life nor improvement ofmyocardium function 
is the objective of the procedure. 
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3 Anterolateral thoracotomy with tile flexible tilt accessing tile anterior left vcntricular wall. 
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4 Sternotomy and pericardial wall with device accessing posterolateral wall. 
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Rcstdts 
Ilistological evaluation of the spcc!mens in the original 
pilot studies using a swine model demonstrated ex- 
tremely enconra~ng observations. All channels were 
found to be fully healed and filled with a eollagenous 
matrix comprising nmltiple types and sizes of vessels. 
Adjacent myocardium, both immediate to the channel 
border and several millimeters away, appeared histo- 
logically intact. No evidence of si~fifieant myoeyte 
dropout, fibrosis, or inflammatory infiltrate was ob- 
served. Unlike TMR laser elmnneling, TMC did not 
produce charring of the channels or coagulation of the 
adjacent myocardial tissue. Significant vascnlarity in 
the healing and adjacent re~ons was identified and 
associated with channel renmants (Fig. 5). A mixture of 
capillaries under 25 microns in diameter, small arte- 
riolcs 25 to 200 microns ill diam-ctcr (Fig. 6); and 
medium-sized arterioles 200 to 400 microns in diameter 
were seen within as well as immediately adjacent o the 
scar resuhing from channel healing. Most imI)ressively , 
in several cases adjacent muscular arteries were iden- 
tiffed with side-1)ranching collaterals infihrating into 
fil)rocollagenous tracks, suggesting a recruitment of ad- 
jacent arterial flow (Fig. 7). Most significant was the 
fact that all study animals tolerated the procedure 
without arrhythmias, changes in ST segment stability, 
or wall motion score variants from baselhle. Considering 
the sensitivity of this aIfimal model, this bodes well for the 
tolerance of the technique l)y humans with iml)aired ven- 
tricular function. Sul)sequent linfited clhfical trials in hu- 
mans have resuhed in a two-class dimhmtion in anghm 
scale with no intraol)erative or perioperative myocardial 
events (Jack Copeland 2000, i)ersonal communication). 
5 Low-power view of tile channel at 60 days. The channel is filled ~,ith fibrous tissue, 
and vessels are seen (arrow) traversing the scarred channel area. 
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6 Intramyocardial channel filled with fibrosis tissue (blue), with vessels intersl)ersed 
within the area of scarring. Note a muscular artery at tile border zone of viable 
myoeardiunl and tile seal- (arrow). 
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7 Intramyocardial muscular artery within tile healthy myocardium that has given rise 
to a smaller artery (arrow) infiltrating into the area of tile channel, wllich is showing 
fibrosis. 
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Collelusions 
Some of the factors limiting tim use of TMR laser 
include high cost, required precautions, and the intra- 
operative anti postoperative clinical consequences of
tim thcrmo-acoustic injury associated with the produc- 
tion of laser channels. Many imtients develop arrhyth- 
mias and myocardial edema and/or stiffening, wlfich 
effectively cause a temporary reduction in cardiac sta- 
lfility anti ventricular function. This is a morbid side 
effect of the procedure in most and perhaps limits the 
TMR's applicability to tlmse with significantly impaired 
vcntricular fnnction. Additionally, there may be some 
hesitation to optimally apply TMR as an adjunctive 
procedure in patients undergoing bypass procedures, 
because of the transitional impairment of vcntricular 
function tlmt may be frequently seen in Imticnts under- 
going transmyocardial laser rcvascularization. These 
l)aticnts, as well as those undcrgoiug an isolated laser 
procedure, are subject o arrhytlmfias and intermedi- 
ate periods of ventricular dysfunction requiring inotro- 
1)ic support and aggressive diuretic theral)y in the im- 
mediate postoperative period. 
It is our hope, as is SUl)ported 1)y the limited initial 
clinical trial, that TMC may effectively address ome of 
the linfiting factors and nmrbid effects challen~,dng 
TMR. The TMC device console is small, mol)ile, and 
siml)le to set up and use. The lmndpicce requires no 
accompanying safety equipment, ires an articulating tip 
to allow full access to the heart from any incision, and 
is activated by a single signal to create channels of a 
precise del)th. With no associated thcrmo-acoustic in- 
jury, myocardial injury is limited and effects on the 
myocardium arc minimal. Finally, tim demonstration 
of not only an~ogenesis, but also of vasculogenesis, 
suggests ul)stantially enllanced perfusion to ischemic 
myocardium. Thus TMC may offer a simple and effec- 
tive option in patients with advanced and symptonmtie 
coronary artery disease. 
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